The role of hypochlorous acid as one of the reactive oxygen species in periodontal disease

Journal of Dental Sciences

Volumn 4, Issue 2, 2009, Pages 45-54

  Sam, Chong Hou ^a   Lu, Hsein Kun ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hypochlorous acid; NF B; Periodontitis; Taurine chloramine; Transcription factor AP 1

Indexed keywords

EID: 68249090800     PISSN: 19917902     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1991-7902(09)60008-8     Document Type: Review

References (71)

1. Chapple IL, Matthews JB. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2000 2007;43:160-232.
2. Mainnemare A, Megarbane B, Soueidan A, Daniel A, Chappie IL. Hypochlorous acid and taurine-N-monochloramine in periodontal diseases. J Dent Res 2004;83:823-31.
3. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 1991;91:S14-22.
4. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997;82:291-5.
5. Battino M, Bullon P, Wilson M, Newman H. Oxidative injury and inflammatory periodontal diseases: the challenge of anti-oxidants to free radicals and reactive oxygen species. Crit Rev Oral Biol Med 1999;10:458-76.
6. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia / reperfusion injury. Pharmacol Rev 2001;53:135-59.
7. Satoh MS, Lindahl T. Enzymatic repair of oxidative DNA damage. Cancer Res 1994; 54(7 Suppl):s1899-901.
8. Canakci CF, Cicek Y, Canakci V. Reactive oxygen species and human inflammatory periodontal diseases. Biochemistry (Mosc) 2005;70:619-28.
9. Fantone JC, Ward PA. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982;107:395-418.
10. Weighardt H, Feterowski C, Veit M, Rump M, Wagner H, Holzmann B. Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J Immunol 2000;165:4537-43.
11. +channel is essential for innate immunity. Nature 2004;427:853-8.
12. Skaleric U, Manthey CM, Mergenhagen SE, Gaspirc B, Wahl SM. Superoxide release and superoxide dismutase expression by human gingival fibroblasts. Eur J Oral Sci 2000;108:130-5.
13. Sculley DV, Langley-Evans SC. Salivary antioxidants and periodontal disease status. Proc Nutr Soc 2002;61:137-43.
14. Bartold PM, Wiebkin OW, Thonard JC. The effect of oxygen-derived free radicals on gingival proteoglycans and hyaluronic acid. J Periodontal Res 1984;19:390-400.
15. Moseley R, Waddington RJ, Embery G, Rees SG. The modification of alveolar bone proteoglycans by reactive oxygen species in vitro. Connect Tissue Res 1998;37:13-28.
16. Chappie IL. Reactive oxygen species and antioxidants in inflammatory diseases. J Clin Periodontol 1997;24:287-96.
17. Jarnbring F, Somogyi E, Dalton J, Gustafsson A, Klinge B. Quantitative assessment of apoptotic and proliferative gingival keratinocytes in oral and sulcular epithelium in patients with gingivitis and periodontitis. J Clin Periodontol 2002; 29:1065-71.
18. Bax BE, Alam AS, Banerji B, et al. Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem Biophys Res Commun 1992;183:1153-8.
19. Hall TJ, Schaeublin M, Jeker H, Fuller K, Chambers TJ. The role of reactive oxygen intermediates in osteoclastic bone resorption. Biochem Biophys Res Commun 1995;207:280-7.
20. Limeback H. Molecular mechanisms in dental hard tissue mineralization. Curr Opin Dent 1991;1:826-35.
21. Fujisawa R, Kuboki Y. Preferential adsorption of dentin and bone acidic proteins on the (100) face of hydroxyapatite crystals. Biochim Biophys Acta 1991;1075:56-60.
22. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990;346:281-4.
23. Moseley R, Waddington RJ, Embery G. Degradation of gly-cosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. Biochim Biophys Acta 1997;1362:221-31.
24. Moseley R, Waddington R, Evans P, Halliwell B, Embery G. The chemical modification of glycosaminoglycan structure by oxygen-derived species in vitro. Biochim Biophys Acta 1995;1244:245-52.
25. Madison SA, McCallum JEB, Rojas Wahl RU. Hydroperoxide formation in model collagens and collagen type I. Int J Cosmet Sci 2002;24:43-52.
26. Monboisse JC, Borel JP. Oxidative damage to collagen. EXS 1992;62:323-7.
27. Rittie L, Monboisse JC, Gorisse MC, Gillery P. Malondialdehyde binding to proteins dramatically alters fibroblast functions. J Cell Physiol 2002;191:227-36.
28. Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 1990;85:632-9.
29. Key LL Jr, Wolf WC, Gundberg CM, Ries WL. Superoxide and bone resorption. Bone 1994;15:431-6.
30. Steinbeck MJ, Appel WH Jr, Verhoeven AJ, Karnovsky MJ. NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone. J Cell Biol 1994;126:765-72.
31. Ozawa T. Mechanism of somatic mitochondrial DNA mutations associated with age and diseases. Biochim Biophys Acta 1995;1271:177-89.
32. Sugano N, Kawamoto K, Numazaki H, Murai S, Ito K. Detection of mitochondrial DNA mutations in human gingival tissues. J Oral Sci 2000;42:221-3.
33. King CC, Jefferson MM, Thomas EL. Secretion and inactiva-tion of myeloperoxidase by isolated neutrophils. J Leukoc Biol 1997;61:293-302.
34. Kontny E, Maslinski W, Marcinkiewicz J. Anti-inflammatory activities of taurine chloramine: implication for immunoreg-ulation and pathogenesis of rheumatoid arthritis. Adv Exp Med Biol 2003;526:329-40.
35. Curtis MA, Aduse-Opoku J, Rangarajan M. Cysteine proteases of Porphyromonas gingivalis. Crit Rev Oral Biol Med 2001; 2:192-216.
36. Prutz WA, Kissner R, Nauser T, Koppenol WH. On the oxidation of cytochrome c by hypohalous acids. Arch Biochem Biophys 2001;389:110-22.
37. Liu ZX, Fridovich I. Negative chemotaxis in Cytophaga johnsonae. Can J Microbiol 1996;42:515-8.
38. Marcinkiewicz J, Czajkowska B, Grabowska A, Kasprowicz A, Kociszewska B. Differential effects of chlorination of bacteria on their capacity to generate NO, TNF-α and IL-6 in macrophages. Immunology 1994;83:611-6.
39. Vissers MC, Winterbourn CC. Oxidation of intracellular glutathione after exposure of human red blood cells to hypochlorous acid. Biochem J 1995;307:57-62.
40. McKenna SM, Davies KJ. The inhibition of bacterial growth by hypochlorous acid. Possible role in the bactericidal activity of phagocytes. Biochem J 1988;254:685-92.
41. Fu X, Kassim SY, Parks WC, Heinecke JW. Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. J Biol Chem 2003;278:28403-9.
42. Reeves EP, Nagl M, Godovac-Zimmermann J, Segal AW. Reassessment of the microbicidal activity of reactive oxygen species and hypochlorous acid with reference to the phagocytic vacuole of the neutrophil granulocyte. J Med Microbiol 2003;52:643-51.
43. Davies JM, Horwitz DA, Davies KJ. Inhibition of collagenase activity by N-chlorotaurine, a product of activated neutrophils. Arthritis Rheum 1994;37:424-7.
44. Michaelis J, Vissers MC, Winterbourn CC. Different effects of hypochlorous acid on human neutrophil metalloproteinases: activation of collagenase and inactivation of collagenase and gelatinase. Arch Biochem Biophys 1992;292:555-62.
45. Thomas EL, Jefferson MM, Learn DB, King CC, Dabbous MK. Myeloperoxidase-catalyzed chlorination of histamine by stimulated neutrophils. Redox Rep 2000;5:191-6.
46. 2M) differentially regulates receptor binding by cytokines/ growth factors: implications for tissue injury and repair mechanisms in inflammation. J Immunol 1998;161:4356-65.
47. 1-proteinase inhibitor. Am J Physiol 1994;266: L593-611.
48. Vogt W. Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Immunobiology 1996;195:334-46.
49. Tatsumi T, Fliss H. Hypochlorous acid and chloramines increase endothelial permeability: possible involvement of cellular zinc. Am J Physiol 1994;267:H1597-607.
50. Grzesik WJ, Narayanan AS. Cementum and periodontal wound healing and regeneration. Crit Rev Oral Biol Med 2002;13:474-84.
51. Chappie IL, Brock G, Eftimiadi C, Matthews JB. Glutathione in gingival crevicular fluid and its relation to local antioxidant capacity in periodontal health and disease. Mol Pathol 2002;55:367-73.
52. Teng YT. The role of acquired immunity and periodontal disease progression. Crit Rev Oral Biol Med 2003;14:237-52.
53. Midwinter RG, Vissers MC, Winterbourn CC. Hypochlorous acid stimulation of the mitogen-activated protein kinase pathway enhances cell survival. Arch Biochem Biophys 2001;394:13-20.
54. Pullar JM, Vissers MC, Winterbourn CC. Glutathione oxidation by hypochlorous acid in endothelial cells produces glutathione sulfonamide as a major product but not glutathione disulfide. J Biol Chem 2001;276:22120-5.
55. Harper R, Wu K, Chang MM, et al. Activation of nuclear factor-?b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetyl-cysteine and glutathione. Am J Respir Cell Mol Biol 2001; 25:178-85.
56. Hirota K, Matsui M, Murata M, et al. Nucleoredoxin, glu-taredoxin, and thioredoxin differentially regulate NF-κB, AP-1, and CREB activation in HEK293 cells. Biochem Biophys Res Commun 2000;274:177-82.
57. Takeuchi J, Hirota K, Itoh T, et al. Thioredoxin inhibits tumor necrosis factor- or interleukin-1 -induced NF-KB activation at a level upstream of NF-?B-inducing kinase. Antioxid Redox Signal 2000;2:83-92.
58. Janssen-Heininger YM, Poynter ME, Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic Biol Med 2000; 28:1317-27.
59. Hidalgo E, Dominguez C. Growth-altering effects of sodium hypochlorite in cultured human dermal fibroblasts. Life Sci 2000;67:1331-44.
60. Kwasny-Krochin B, Bobek M, Kontny E, et al. Effect of taurine chloramine, the product of activated neutrophils, on the development of collagen-induced arthritis in DBA 1 / J mice. Amino Acids 2002;23:419-26.
61. Park E, Jia J, Quinn MR, Schuller-Levis G. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin Immunol 2002;102:179-84.
62. Park E, Quinn MR, Schuller-Levis G. Taurine chloramine attenuates the hydrolytic activity of matrix metalloproteinase-9 in LPS-activated murine peritoneal macrophages. Adv Exp Med Biol 2000;483:389-98.
63. Liu Y, Barua M, Serban V, Quinn MR. Production of inflammatory mediators by activated C6 cells is attenuated by taurine chloramine inhibition of NF-κBactivation. Adv Exp Med Biol 2003;526:365-72.
64. Barua M, Liu Y, Quinn MR. Taurine chloramine inhibits inducible nitric oxide synthase and TNF-α gene expression in activated alveolar macrophages: decreased NF-κB acti-vation and IκB kinase activity. J Immunol 2001; 167:2275-81.
65. 2 synthesis in rheumatoid arthritis synoviocytes by taurine chloramine. Arthritis Rheum 2003; 48:1551-5.
66. Kanayama A, Inoue J, Sugita-Konishi Y, Shimizu M, Miyamoto Y. Oxidation of IKBα.at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-κBactivation. J Biol Chem 2002;277:24049-56.
67. Selkon JB, Cherry GW, Wilson JM, Hughes MA. Evaluation of hypochlorous acid washes in the treatment of chronic venous leg ulcers. J Wound Care 2006;15:33-7.
68. Yahagi N, Kono M, Kitahara M, et al. Effect of electrolyzed water on wound healing. Artif Organs 2000;24:984-7.
69. Kozol RA, Gillies C, Elgebaly SA. Effects of sodium hypochlorite (Dakin's solution) on cells of the wound module. Arch Surg 1988;123:420-3.
70. Kjolseth D, Frank JM, Barker JH, et al. Comparison of the effects of commonly used wound agents on epitheliali-zation and neovascularization. J Am Coll Surg 1994;179: 305-12.
71. Wang L, Bassiri M, Najafi R, et al. Hypochlorous acid as a potential wound care agent, part I: stabilized hypochlorous acid: a component of the inorganic armamentarium of innate immunity. J Burns Wounds 2007;6:e5.